SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001140361-22-014299
Filing Date
2022-04-13
Accepted
2022-04-13 12:30:18
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC14D9C ny20002681x2_sc14d9c.htm SC14D9C 48591
2 EXHIBIT 2.1 ny20002681x2_ex2-1.htm EX-2.1 493869
3 EXHIBIT 3.1 ny20002681x2_ex3-1.htm EX-3.1 5157
4 EXHIBIT 99.1 ny20002681x2_ex99-1.htm EX-99.1 35465
  Complete submission text file 0001140361-22-014299.txt   585264
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filed by) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Subject) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-47575 | Film No.: 22824178
SIC: 3841 Surgical & Medical Instruments & Apparatus